Hansen S K, Guerrini L, Blasi F
Department of Genetics and Microbiol Biology, University of Milano, Italy.
J Biol Chem. 1994 Sep 2;269(35):22230-7.
The cRel-RelA and NF-kappa B (p50-RelA) transcription factors bind to a kappa B-like sequence termed Rel-related proteins binding element localized in the regulatory region of the human urokinase plasminogen activator (uPA) gene. This sequence is highly conserved in murine and porcine uPA genes where it retained the ability to associate with cRel-RelA. On the other hand, NF-kappa B binding was obtained with the human and porcine elements only. Methylation interference analysis showed that NF-kappa B and cRel-RelA had identical interference patterns. Mutational analysis showed that DNA binding was highly sensitive to mutations within the decameric Rel-related proteins binding element core site. However, alterations of nucleotides flanking the decameric IgK-kappa B motif, which preferentially associated with NF-kappa B, resulted in high affinity cRel-RelA binding both in vitro and in vivo. These data demonstrate that NF-kappa B and cRel-RelA have overlapping but distinct DNA sequence specificities. Bandshift analysis with HeLa and Jurkat cell extracts or with in vitro translated proteins revealed that the SV40-, HIV-1-, and interleukin-2 receptor alpha subunit kappa B elements efficiently associated with cRel-RelA, suggesting that this heterodimer may be involved in the regulation of several genes. Cotransfection studies of HIV-1 long terminal repeat-chloramphenicol acetyltransferase reporter DNA with RelA, cRel, and p50 expression vectors were performed in COS7 and U293 cells to analyze the ability of cRel-RelA to regulate HIV-1 enhancer activity. In vivo formation of the cRel-RelA complex resulted in specific stimulation of the viral enhancer at a level comparable with that obtained with NF-kappa B. These data suggest that activation of cellular cRel-RelA may play a critical role in the regulation of HIV-1 enhancer activity.
cRel-RelA和核因子κB(p50-RelA)转录因子与一种类κB序列结合,该序列被称为Rel相关蛋白结合元件,定位于人尿激酶型纤溶酶原激活剂(uPA)基因的调控区域。此序列在鼠和猪的uPA基因中高度保守,且保留了与cRel-RelA结合的能力。另一方面,仅人源和猪源元件能获得核因子κB结合。甲基化干扰分析表明,核因子κB和cRel-RelA具有相同的干扰模式。突变分析显示,DNA结合对十聚体Rel相关蛋白结合元件核心位点内的突变高度敏感。然而,优先与核因子κB结合的十聚体IgK-κB基序侧翼核苷酸的改变,在体外和体内均导致cRel-RelA的高亲和力结合。这些数据表明,核因子κB和cRel-RelA具有重叠但不同的DNA序列特异性。用HeLa和Jurkat细胞提取物或体外翻译的蛋白进行的凝胶迁移分析表明,SV40、HIV-1和白细胞介素-2受体α亚基的κB元件能有效地与cRel-RelA结合,提示这种异二聚体可能参与多个基因的调控。在COS7和U293细胞中进行了HIV-1长末端重复序列-氯霉素乙酰转移酶报告基因DNA与RelA、cRel和p50表达载体的共转染研究,以分析cRel-RelA调节HIV-1增强子活性的能力。cRel-RelA复合物在体内的形成导致病毒增强子的特异性刺激,其水平与核因子κB相当。这些数据提示,细胞cRel-RelA的激活可能在HIV-1增强子活性的调控中起关键作用。